Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase.

about

A Review of Selected Studies That Determine the Physical and Chemical Properties of Saliva in the Field of Dental Treatment.

P2860

Q55032264-63FD9DAB-A5A7-48B8-8551-B59E82CEB448

P2860

Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase.

Item

http://www.wikidata.org/entity/Q35609720

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Effects of methamphetamine on ...... marker salivary alpha-amylase.

@ast

Effects of methamphetamine on ...... marker salivary alpha-amylase.

@en

type

Item

label

Effects of methamphetamine on ...... marker salivary alpha-amylase.

@ast

Effects of methamphetamine on ...... marker salivary alpha-amylase.

@en

prefLabel

Effects of methamphetamine on ...... marker salivary alpha-amylase.

@ast

Effects of methamphetamine on ...... marker salivary alpha-amylase.

@en

P1476

Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase

@en

P2093

Colin N Haile

http://www.w3.org/2001/XMLSchema#string

James J Mahoney

http://www.w3.org/2001/XMLSchema#string

Richard De La Garza

http://www.w3.org/2001/XMLSchema#string

Thomas F Newton

http://www.w3.org/2001/XMLSchema#string

P2860

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

How addictive drugs disrupt presynaptic dopamine neurotransmission

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

A review of the clinical pharmacology of methamphetamine

Noradrenergic α₁ receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial

The combined propranolol/TSST paradigm--a new method for psychoneuroendocrinology

Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine.

There and back again: a tale of norepinephrine and drug addiction.

Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research.

The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial.

P304

759-762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUGALCDEP.2013.07.029

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256084645

http://www.w3.org/2001/XMLSchema#string

P698

23968815

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4432865

http://www.w3.org/2001/XMLSchema#string

Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase.

about

P2860

P2860

Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932